'St I N D U S T R I A L SUPPLEMENTAL INFORMATION UNAUDITED THIRD QUARTER 2024 Golden, CO Londonderry, NH Preparer Sync/Link Approver NA Jeff M. 10/20/2017 Peter F. 10/23/2017 1 1 1 1 Forward-Looking Statements This supplemental information package contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. STAG Industrial, Inc. (STAG) intends such forward-looking statements to be ...

CONFIDENTIAL Q3'24 Results presentation 30 October 2024 CONFIDENTIAL Opening remarks 2 Q3'24 performance • Income up 12% YoY with record performance in Wealth Solutions • Continued cost discipline with expenses up 2% YoY; Fit for Growth programme well underway • TNAV per share up 18% YoY to $15.09 Upgraded guidance • Income growth towards 10% in 2024 • Shareholder distributions of at least $8bn for 2024-2026 • RoTE approaching 13% in 2026 ▶ Overview Income Expenses Impairment Balance sheet Capital Business ...

| --- | --- | --- | |------------------------------------------------------|-------|-------| | | | | | | | | | Third Quarter 2024 Financial Review October 30, 2024 | | | | | | | 3Q 2024 EARNINGS RELEASE 2 Caterpillar: Confidential Yellow Forward-Looking Statements Certain statements in this financial review relate to future events and expectations and are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "estimate," "will be," "wi ...

| --- | --- | --- | --- | --- | |-------|-------|----------------------------|---------------|-------| | | | | | | | | | Q3 2024 October 30, 2024 | Earnings Call | | | | | | | | | --- | --- ...

Advancing Life-Changing Discoveries in Neuroscience Q3 2024 Corporate Presentation October 30, 2024 Nasdaq: NBIX Safe Harbor Statement and Non-GAAP Financial Measures 2 In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product candidates may bring t ...

3Q 2024 Earnings Presentation October 30, 2024 © 2024 GE HealthCare. GE is a trademark of General Electric Company used under trademark license. Forward-looking statements and additional information This presentation contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," "believe," "anticipate," "intend," "estimate," "potential," "position," "forecast," "target," "guidance," "outl ...

UMC UNITED FOR EXCELLENCE UMC 3Q24 Financial Review October 30, 2024 NOTE CONCERNING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended, and as defined in the United States Private Securities Litigation Reform Act of 1995. These forward looking statements include, but are not limited to, statements relating t ...

_ .. | --- | --- | --- | --- | |------------------|-------|-------|-------| | | | | | | Q3 2024 Earnings | | | | | Results Review | | | | | | | | | | October 30, 2024 | | | | 2 • Today's presentation includes forward-looking statements that reflect Bunge's current views with respect to future events, financial performance and industry conditions. 2 Forward-Looking Statements • These forward-looking statements are subject to various risks and uncertainties. Bunge has provided additional information in its re ...

TUESDAY, OCTOBER 29, 2024 Third Quarter 2024 Financial Results Nasdaq: EXEL EXELIXIS® Today's Agenda Introduction Varant Shirvanian Director, Investor Relations Business Update and Q3 2024 Highlights Michael M. Morrissey, Ph.D. President and CEO Financial Results & Guidance Chris Senner EVP and CFO Commercial Update PJ Haley EVP, Commercial Q&A All, joined by: Amy Peterson, M.D. EVP, Product Development and Medical Affairs and CMO Dana T. Aftab, Ph.D. EVP, Discovery and Translational Research and CSO 2 Safe ...

ûdemy 1 Earnings Presentation Q3 2024 October 29, 2024 Safe Harbor Notice This presentation and any accompanying oral commentary include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements other than those of historical fact, including information concerning our future operating results and financial position, anticipated future expenses and investments, business strategies and plans, market growth, market p ...